Free Trial

C4 Therapeutics (CCCC) SEC Filings & 10K Form

C4 Therapeutics logo
$1.25 +0.15 (+13.64%)
Closing price 04:00 PM Eastern
Extended Trading
$1.22 -0.03 (-2.40%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent C4 Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2025
6:46 AM
C4 Therapeutics (Filer)
Form PRE 14A
04/14/2025
7:17 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:19 AM
C4 Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:07 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:15 AM
C4 Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/03/2025
12:59 PM
C4 Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G
01/14/2025
6:09 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:49 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:11 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:43 PM
C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:53 PM
C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
5:43 PM
C4 Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
8:01 AM
C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
Form SC 13G/A
11/13/2024
11:15 PM
C4 Therapeutics (Filer)
Form EFFECT
11/13/2024
11:15 PM
C4 Therapeutics (Filer)
Form EFFECT
11/13/2024
3:57 PM
C4 Therapeutics (Filer)
Form SUPPL
11/13/2024
3:58 PM
C4 Therapeutics (Filer)
Form SUPPL
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
Form SC 13G
10/31/2024
4:26 PM
C4 Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/31/2024
4:27 PM
C4 Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/31/2024
6:07 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:12 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
3:30 PM
C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2024
3:31 PM
C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
Form SC 13G
10/18/2024
3:45 PM
C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:11 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:37 PM
C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:10 PM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:11 PM
C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:12 PM
C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:12 PM
C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:12 PM
Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:12 PM
Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:12 PM
C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:51 PM
C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
3:52 PM
C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
6:06 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:27 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
6:11 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
5:47 AM
C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
06/11/2024
3:45 PM
C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2024
3:46 PM
C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:41 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:10 AM
C4 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:07 AM
C4 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:52 AM
C4 Therapeutics (Filer)
Form ARS
04/29/2024
7:03 AM
C4 Therapeutics (Filer)
Form DEF 14A
04/29/2024
7:04 AM
C4 Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CCCC) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners